Lumenis Aesthetic Division

What Lumenis Aesthetic Division does

Lumenis Aesthetic Division is the aesthetics business segment of Lumenis Be Ltd., an Israel-incorporated medical device company owned by EQT Private Capital Asia and founded in the mid-1960s. The division designs, manufactures, and commercializes energy-based medical devices — spanning CO2 lasers, IPL (Intense Pulsed Light), RF (radio frequency), Nd:YAG, diode, and Dynamic Muscle Stimulation (DMSt) technologies — for dermatologists, plastic surgeons, aesthetic physicians, medical spas, ophthalmologists, and optometrists. With 1,001–5,000 employees, an installed base of 90,000+ devices, and a commercial footprint spanning 88+ countries, the division operates as a multi-decade incumbent in the energy-based aesthetic medical device market.

The product portfolio includes the Stellar M22 modular platform (combining IPL, ResurFX, Multi-spot Nd:YAG, and Q-Switched Nd:YAG modules), the triLift facial muscle stimulation system (using proprietary DMSt technology, with patent-pending IP), FoLix (the first FDA-cleared non-ablative fractional laser for hair loss), SPLENDOR X dual-wavelength hair removal, UltraPulse Alpha CO2 laser, AcuPulse, Legend Pro+, LightSheer QUATTRO, NuEra Tight, FemTouch, and SmoothGlo. Supporting technologies include patented SureSpot optics, CoolScan non-sequential scanning algorithms, SmartPulse sub-threshold photocoagulation, TriPollar RF, triFX RF microneedling, and BLEND X dual-wavelength technology. The division also supports a Vision segment offering (OptiLIGHT IPL, OptiPLUS RF, OptiLIFT, Digital Duet/Trio, Smart532, Vision One, Array LaserLink, LumeProbe probes) for dry eye disease, glaucoma, and retinal indications, with 500+ clinical publications underpinning the technology platform.

Lumenis monetizes primarily through enterprise field sales of high-value capital equipment to licensed healthcare practitioners under quote-based, non-public pricing. The go-to-market pairs a consultative direct sales force with bundled clinical training, practice marketing support (social media assets, advertising templates, car wrap programs, signage), and consumer-facing provider locators (trilift.me, smoothglo.com, treatmydryeye.com) that drive patient pull-through. Revenue streams include one-time capital device sales plus recurring accessories, consumables, and service contracts. Strategic channel partnerships — notably with Bosley (the largest U.S. hair restoration chain) and clinical validation partners including NYU Dermatology and Bauman Medical — anchor enterprise distribution, while the bulk of the install base consists of mid-market and SMB aesthetic practices across dermatology, plastic surgery, ophthalmology, and medical spa segments.

Name

Lumenis Aesthetic Division

Legal name

Lumenis Be Ltd.

Website

https://lumenis.com

Company type

Private

Founded year

1964

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Lumenis Aesthetic Division is the aesthetics business unit of Israel-based Lumenis Be Ltd., a PE-backed (EQT Private Capital Asia) medical device company founded in the 1960s. It designs and sells energy-based aesthetic and vision systems — laser, IPL, RF, and DMSt — to licensed practitioners across 88+ countries.

Ownership category

akta.pro rank

Product category

Medical Aesthetic Devices

NAICS

Ophthalmic Goods Manufacturing (339115)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Laser & Energy-Based Dermatology (HLAKACAF)

Keywords

• Energy-based aesthetic devices
• Medical aesthetic lasers
• IPL systems
• Radio frequency platforms
• Fractional laser technology

Headquarters

HQ city

Yoqne`am `illit

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Medical Device Hardware Sales: Lumenis generates revenue primarily through the sale of capital medical equipment devices to aesthetic practices, dermatology clinics, plastic surgery centers, ophthalmology practices, and medical spas. Devices are sold as one-time capital purchases with multi-year useful lives. The sales motion is enterprise/field sales with contract negotiation, installation, and clinical training included. Accessories, consumables, and service contracts represent additional revenue streams post-installation.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels9 records

Core offering

Lumenis Aesthetic Division manufactures and sells capital energy-based medical devices for aesthetic and vision practices. Its portfolio spans CO2 lasers, IPL, Nd:YAG, diode, and radiofrequency systems used for skin resurfacing, hair removal, body contouring, facial muscle stimulation, hair loss treatment, women's health, and women's health applications. Customers are licensed practitioners — dermatologists, plastic surgeons, aesthetic physicians, medical spas, and ophthalmologists — purchasing devices through enterprise field sales with installation, training, and post-sale service.

Product overview

Lumenis Aesthetic Division offers a comprehensive portfolio of energy-based medical devices for aesthetic and vision applications. The aesthetic portfolio centers on multi-platform systems (Stellar M22, M22, Legend Pro+) that support interchangeable modules for diverse treatments, complemented by specialized standalone devices (triLift, FoLix, UltraPulse Alpha, AcuPulse, SPLENDOR X, LightSheer QUATTRO, NuEra Tight, FemTouch, SmoothGlo). The vision portfolio includes diagnostic and therapeutic ophthalmic devices (OptiLIGHT, OptiPLUS, OptiLIFT for dry eye; Digital Duet/Digital Trio for glaucoma; Smart532, Vision One, Array LaserLink for retinal treatments), plus surgical accessories (LumeProbe probes, LaserLink slit lamp adapters). The company pioneered CO2 laser technology, IPL, and RF-based treatments, with over 60 years of innovation in energy-based medical aesthetics and ophthalmology.

Differentiator

Problem solved

Functional benefit

Brands

• Pollogen: Product line brand for aesthetic energy-based treatment devices.

Products and services

• FoLix The first and only FDA-cleared non-ablative fractional laser (NAFL) for hair loss, using proprietary NAFL technology to create microscopic thermal zones (MTZs) that stimulate hair follicles by activating the body's natural healing processes. Designed for dermatologists, hair restoration specialists, and aesthetic practices.
• triLift Facial muscle stimulation device using Dynamic Muscle Stimulation (DMSt) technology combined with TriPollar RF and triFX RF microneedling to tone facial muscles, reduce wrinkles, and resurface skin for a facelift-like effect without surgery. For dermatologists, plastic surgeons, and aesthetic physicians.
• Stellar M22 Multi-application modular aesthetic platform offering IPL, ResurFX fractional non-ablative laser, Multi-spot Nd:YAG, and Q-Switched Nd:YAG modules for pigmentation, vascularity, skin resurfacing, and tattoo removal treatments across multiple skin types.
• SPLENDOR X Laser hair removal device featuring dual wavelength technology combining Alexandrite and Nd:YAG lasers with Square Pulse technology for hair removal across all skin types.
• UltraPulse Alpha High-power CO2 laser for aesthetic medicine featuring DeepFX, ActiveFX, TotalFX, and SCAAR FX modes for skin resurfacing, scar revision, and treatment of deep lesions.
• Legend Pro+ 4-in-1 skin treatment platform combining TriPollar RF for volumetric heating, VoluDerm RF-assisted micro-needling, and TriFractional technology for skin rejuvenation, collagen regeneration, and muscle toning.
• LightSheer QUATTRO Diode laser hair removal system using vacuum-assisted technology and 805nm wavelength for hair reduction with built-in cooling.
• NuEra Tight Radio frequency body treatment device for skin tightening and fat reduction using deep tissue RF heating technology.
• AcuPulse Versatile CO2 laser system with 10 built-in treatment modes for fractional and full ablative resurfacing, addressing over 30 FDA-cleared aesthetic indications including sun damage, acne scars, and blepharoplasty.
• M22 Modular multi-application aesthetic platform supporting Universal IPL, Multi-spot Nd:YAG, ResurFX, and Q-Switched Nd:YAG modules for comprehensive skin treatments.
• FemTouch CO2 laser device for women's health applications including vaginal rejuvenation and treatment of vaginal atrophy symptoms.
• SmoothGlo Sequential treatment combining intense pulsed light (IPL) technology with radio frequency (RF) micro-needling to address skin tone, texture, and volume loss with minimal downtime.
• OptiLIGHT IPL device specifically FDA-cleared for treatment and management of dry eye disease caused by Meibomian Gland Dysfunction (MGD). Used by ophthalmologists and optometrists.
• OptiPLUS Dual frequency RF technology complementing OptiLIGHT for comprehensive dry eye disease treatment and management.
• OptiLIFT Non-surgical device using dynamic muscle stimulation to tone periorbital muscles and address droopy eyelids. Received Health Canada Approval for reducing signs and symptoms of evaporative dry eye disease.
• Digital Duet All-in-one digital platform combining SLT (Selective Laser Trabeculoplasty) and YAG photodisruptor technologies for glaucoma and posterior capsule opacification (PCO) therapies.
• Digital Trio 3-in-1 digital platform for glaucoma and retina care combining SLT, YAG, and Smart532 photocoagulation technologies.
• Smart532 Green photocoagulator featuring SmartPulse sub-threshold technology for retinal photocoagulation treatments.
• Vision One Multi-wavelength photocoagulator offering green, yellow, and red wavelengths for versatile retinal treatment options.
• Array LaserLink Pattern scanning laser technology for photocoagulation, enabling automated multi-spot treatment patterns for efficient retinal procedures.
• LumeProbe Premium ophthalmic endo-photocoagulation laser probes in straight, curved, aspirating, illuminating, and stepped configurations in 20, 23, and 25 gauge sizes for vitrectomy procedures, with >8% enhanced transmission efficiency vs. adapter-dependent probes.
• LaserLink Slit Lamp Adapters Slit lamp adapters (LaserLink Z and LaserLink HS) that convert diagnostic slit lamps into precise laser delivery systems using SureSpot optics technology.
• ResurFX Non-ablative fractional resurfacing module using 1565nm fiber laser with CoolScan technology for skin texture improvement and collagen stimulation, designed for use with the M22 platform.

Quantifiable outcome

• FoLix retrospective study: 96.9% of independent board-certified dermatologists correctly identified before-and-after images in review of 98 patients aged 21-66 after 3-6 treatments; no adverse events reported
• +6 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Bosley (Hair Restoration)coreStrategic or Co-development PartnerBosley is the largest hair restoration chain in the United States. Lumenis' collaboration with Bosley has accelerated clinical adoption of FoLix fractional laser for hair loss and expanded patient access across Bosley's national clinic network. Within the first year, FoLix established presence across North America, the Middle East, and Asia-Pacific driven in part by this partnership.
• NYU Dermatology DepartmentcoreStrategic or Co-development PartnerNYU Dermatology Department is a clinical partner for FoLix technology validation, contributing to the clinical evidence base and adoption of Lumenis' hair loss treatment within academic dermatology.
• Bauman Medical (Dr. Bauman)coreStrategic or Co-development PartnerRenowned hair restoration specialist Dr. Bauman and Bauman Medical serve as a clinical partner for FoLix fractional laser technology, contributing to clinical validation and provider education for hair loss treatments.
• Dr. Ronda FarahminorStrategic or Co-development PartnerDr. Ronda Farah is a clinical partner contributing to FoLix technology adoption and validation in hair loss treatment.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Iridex: Ophthalmic laser systems manufacturer focused on retinal and glaucoma therapy, directly competing with Lumenis' Vision division photocoagulators (Smart532, Vision One) and SLT/YAG platforms.
• InMode: Aesthetic and women's health medical device company offering RF, laser, and plasma technologies overlapping with Lumenis' Legend Pro+, triLift, and FemTouch categories in the same practice customer base.
• Fotona: Manufacturer of high-performance laser systems (Er:YAG, Nd:YAG) used across aesthetics and surgery — competing directly with Lumenis' CO2 and Nd:YAG platforms in dermatology and plastic surgery channels.
• Cutera: Medical aesthetic device company providing laser and energy-based systems for skin, hair, and body treatments, overlapping directly with Lumenis' Stellar M22, SPLENDOR X, and similar offerings.
• Candela Medical: Global medical aesthetic device company supplying laser and IPL systems to dermatologists and plastic surgeons, directly overlapping with Lumenis' energy-based treatment portfolio.
• Solta Medical (Bausch + Lomb): Premium aesthetic device maker with franchises (Thermage, Fraxel, Clear+Brilliant) competing head-to-head against Lumenis' UltraPulse Alpha, ResurFX, and other resurfacing/energy platforms in dermatology practices.
• Alma Lasers: A direct competitor offering lasers, RF, and ultrasound-based platforms across hair removal, skin rejuvenation, and body contouring sold to dermatology and medspa customers.
• Cynosure (Hologic): A global aesthetic energy-based device manufacturer directly competing with Lumenis across laser hair removal, IPL, and body contouring categories with comparable practice-channel sales motions.

Emerging players

• Venus Concept: Medical aesthetic technology company selling RF and laser platforms targeting medspas and dermatology practices with overlapping indications to Lumenis' NuEra Tight and hair-removal devices.
• Sciton: US-based aesthetic laser manufacturer with platforms for skin resurfacing and rejuvenation, competing with Lumenis' UltraPulse Alpha and ResurFX in the dermatology channel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/lumenisinc
• YouTubeyoutube.com/user/Lumenis
• LinkedInlinkedin.com/company/11124
• Instagraminstagram.com/lumenis
• Facebookfacebook.com/lumenis

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lumenis Aesthetic Division